Old Web
English
Sign In
Acemap
>
authorDetail
>
Andrea Groenewegen
Andrea Groenewegen
Novartis
Placebo
Pharmacokinetics
Medicine
Omalizumab
Basophil
3
Papers
26
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
First‐in‐human clinical trial to assess pharmacokinetics, pharmacodynamics, safety and tolerability of iscalimab, an anti‐CD40 monoclonal antibody
2019
American Journal of Transplantation
Pascal Espie
Yan-Ling He
Phillip Koo
Denise Sickert
Cyrielle Dupuy
Edwige Chokote
Roland Schuler
Heidi Mergentaler
Jacinda Ristov
Julie Milojevic
Aurelie Verles
Andrea Groenewegen
Anita Auger
Alexandre Avrameas
Michael Rotte
Laurence Colin
Charles S. Tomek
Martha Hernandez‐Illas
James S Rush
Peter Gergely
Show All
Source
Cite
Save
Citations (23)
Efficacy and safety of QGE031, a novel anti-IgE antibody, in atopic subjects
2014
Jonathan Arm
Ivan Bottoli
Andrej Skerjanec
Andrea Groenewegen
Suzanne Maahs
Charles Owen
Ieuan Jones
Philip J. Lowe
Show All
Source
Cite
Save
Citations (0)
QGE031 high affinity anti-IgE: Tolerability, safety, pharmacokinetics and pharmacodynamics in atopic subjects
2013
European Respiratory Journal
Jonathan P. Arm
Ivan Bottoli
Andrej Skerjanec
Andrea Groenewegen
Phil Lowe
Suzanne Maahs
Show All
Source
Cite
Save
Citations (3)
1
map